ENDV is heading to dollars.

DD:
http://www.pharmaceutical-journal.com/news-an...49.article

http://endonovo.com/cytotronics-platform/ (ENDV has Multiple Platforms!)

http://endonovo.com/tvemf-vs-pemf/

http://nypost.com/2017/04/12/apple-has-a-secr...reatments/

https://www.google.com/amp/mobile.reuters.com...SKCN10C1K8

http://smallcapexclusive.com/duggan-robert-pi...se-shares/

https://www.forbes.com/profile/robert-duggan/

ENDV is the leader Bio electronics further along than Apple & Google/GSK Galvani Bio sciences subsidiary, and Pulse Biosciences

PLSE market cap 480 Million. Robert Duggan the founder of PCYC sold for 21 Billion just took a 19% stake in PLSE

The President of ENDV has spent half his salary over the last 12 months buying open market shares of ENDV every week. At an average cost of .26 He owns close to 21 Million shares. Total insiders hold over 41 million shares.

Bring on the epic short squeeze. & the Milestone updates.

Anything under .25 is a gift.

https://twitter.com/endonovo